Atlas Trials

Terumo Europe N.V.

24 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Terumo Europe N.V.

RecordFirmDate
BioPearl™ Microspheres Loaded With Doxorubicin for the Treatment of Unresectable Hepatocellular Carcinoma (HCC) (NCT05911633)Terumo Europe N.V.2024-02-27
Holmium-166 Transarterial Radioembolization in Unresectable, Early Stage Hepatocellular Carcinoma. (NCT05451862)Terumo Europe N.V.2023-08-21
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients (NCT05705973)Terumo Europe N.V.2023-04-25
Post-market Clinical Investigation of the Angio-Seal™ VIP VCD (ANGIO-SEAL CLOSE) (NCT05335525)Terumo Europe N.V.2022-09-30
Holmium-166 Retrospective Collection of Real-World Data (NCT05111795)Terumo Europe N.V.2022-01-17
Post-Market Clinical Investigation of the FemoSeal™ VCS: A Prospective, Multi-Center Observational European Study (NCT05027698)Terumo Europe N.V.2021-12-27
Prospective Multicenter Study to Confirm the Performance of the Renzan Stent in Treatment of SFA/POP Artery Disease (NCT04546477)Terumo Europe N.V.2020-07-30
DIStal Versus COnventional RADIAL Access for Coronary Angiography and Intervention (NCT04171570)Terumo Europe N.V.2019-12-10
QuiremSpheres Observational Study (NCT03563274)Terumo Europe N.V.2018-06-21
Prospective Single Arm CAS - ROADSAVER Study (NCT03504228)Terumo Europe N.V.2018-01-23

Track Terumo Europe N.V. automatically

Every clearance here is in the API, with alerts when new ones post.